Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti ‐tumor properties of PEDF with various efficacy and toxicity

The Prostate, EarlyView.

Source: The Prostate - May 11, 2018 Category: Urology & Nephrology Authors: Courtney Jarvis , Thomas Nelius , Dalia Martinez ‐Marin , Souad R. Sennoune , Stéphanie FilleurPhD Source Type: research